Jul 10, 2025, 08:40

AACR Immuno-oncology Research Fellowship

The AACR Immuno-oncology Research Fellowship supports postdoctoral or clinical research fellows in conducting cutting-edge basic, translational, clinical, or population sciences investigations directly applicable to immuno-oncology. Awardees receive two years of support—including salary, benefits, and research expenses—to establish a successful independent research career in this rapidly evolving field.

Eligibility Criteria:

Hold a doctoral degree (PhD, MD, MD/PhD, or equivalent) conferred on or after November 1, 2020.
At the start of the grant term (November 1, 2025), be appointed as a postdoctoral fellow, clinical research fellow, or equivalent in a mentored research position at an academic, medical, or research institution anywhere in the world.
Dedicate at least 50% effort to the proposed immuno-oncology research project.
Have mentorship confirmed by a letter from an AACR-member mentor (or co-mentors) and an institutional signing official.
Be an AACR member in good standing by the application deadline (members in eligible low-capacity countries may qualify for dues waiver).
Not hold a current AACR grant that overlaps in term, nor be employed by a U.S. government entity or for-profit industry.

Funding Details:

Total award: 130,000 USD over two years.
Minimum 50% of funds for fellow’s salary and benefits.
Up to 50% may be used for research-related expenses (supplies, equipment, publication charges).
Up to $2,000 for travel/registration to the Annual Grantee Recognition Event; up to 1,500 USD for the Grantee Summit.
Equipment purchases over 10% of budget require detailed justification.

Deadline:

Applications must be submitted by July 29, 2025, at 1:00 p.m. U.S. Eastern Time (applicants should confirm in their local time zone).

Where to Go for Further Information:

Applications and full guidelines are available on ProposalCentral:
General inquiries: [email protected].

AACR American Association for Cancer Research biomedical research cancer Cancer research clinical research fellowship immuno-oncology OncoDaily Oncology Postdoctoral proposalCENTRAL

25 Posts Not To Miss From ESMO GI 2025

Botensilimab and Balstilimab Show Durable Survival in MSS Colorectal Cancer: ESMO GI 2025 Update

Julian McMahon Dies at 56: A Look Back at His Private Cancer Battle and Legendary Acting Career

Vivek Subbiah: It’s Time We Evolve WHO Cancer Classification

ESMO 50th Anniversary: Half a Century of Evidence-Based Cancer Care